Detalhe da pesquisa
1.
Enrollment of older metastatic breast cancer patients in first-line clinical trials: 9-year experience of the large-scale real-life multicenter French ESME cohort.
Breast Cancer Res Treat
; 191(3): 577-587, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34984582
2.
Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study.
Ann Oncol
; 27(9): 1725-32, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27436849
3.
Real-World Data on Newly Diagnosed BRCA-Mutated High-Grade Epithelial Ovarian Cancers: The French National Multicenter ESME Database.
Cancers (Basel)
; 14(16)2022 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36011033
4.
Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database.
ESMO Open
; 6(3): 100150, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33984675
5.
Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort.
ESMO Open
; 6(3): 100114, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33895695
6.
Endocrine therapy or chemotherapy as first-line therapy in hormone receptor-positive HER2-negative metastatic breast cancer patients.
Eur J Cancer
; 95: 93-101, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29655061